MDPI and ACS Style
Sani, S.; Pallaoro, N.; Messe, M.; Bernhard, C.; Etienne-Selloum, N.; Kessler, H.; Marinelli, L.; Entz-Werle, N.; Foppolo, S.; Martin, S.;
et al. Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin. Cancers 2022, 14, 369.
https://doi.org/10.3390/cancers14020369
AMA Style
Sani S, Pallaoro N, Messe M, Bernhard C, Etienne-Selloum N, Kessler H, Marinelli L, Entz-Werle N, Foppolo S, Martin S,
et al. Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin. Cancers. 2022; 14(2):369.
https://doi.org/10.3390/cancers14020369
Chicago/Turabian Style
Sani, Saidu, Nikita Pallaoro, Mélissa Messe, Chloé Bernhard, Nelly Etienne-Selloum, Horst Kessler, Luciana Marinelli, Natacha Entz-Werle, Sophie Foppolo, Sophie Martin,
and et al. 2022. "Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin" Cancers 14, no. 2: 369.
https://doi.org/10.3390/cancers14020369